Poranki, Deepika | Washington University Office of Technology Management

Intestinal biomarker predicts response to treatment for inflammatory bowel disease

by | May 18, 2020 | Stappenbeck, Thaddeus, VanDussen, Kelli

— Technology Description

Researchers in the Stappenbeck lab have discovered an objective histologic biomarker on intestinal cells that can predict a patient’s response to ustekinumab treatment for Crohn’s disease or ulcerative colitis. Specifically, the length of microvilli (MV) could pr…

Human Monoclonal Antibodies: MD.03.1H06, MD.03.1B06, MD.03.1D11, MD.031F03, MD.03.1F11, MD.03.1H01, MD.025.2H09, MD.03.1G01, MD.025.2F10, MD.025.2B07, MD.025.2G11, MD.025.1F09, MD.025.1D01, MD.025.1H07, 306.012.7.1C10, 306.012.7.1A05, 10.036.7.1B04, 10.04.7.1B03

by | Apr 8, 2020 | Ellebedy, Ali

— Human Monoclonal Antibodies: MD.03.1H06, MD.03.1B06, MD.03.1D11, MD.031F03, MD.03.1F11, MD.03.1H01, MD.025.2H09, MD.03.1G01, MD.025.2F10, MD.025.2B07, MD.025.2G11, MD.025.1F09, MD.025.1D01, MD.025.1H07, 306.012.7.1C10, 306.012.7.1A05, 10.036.7.1B04, 10.04.7.1B03

« Older Entries

Next Entries »

Name	# Summaries	Author
Cardiovascular	15	peek
COVID-19	13	peek
Immuno-Oncology	15	peek
Oncology	26	peek
PET Tracers	14	peek
Radiology	14	peek

WASHU INNOVATION CATALOG

Intestinal biomarker predicts response to treatment for inflammatory bowel disease

Human Monoclonal Antibodies: MD.03.1H06, MD.03.1B06, MD.03.1D11, MD.031F03, MD.03.1F11, MD.03.1H01, MD.025.2H09, MD.03.1G01, MD.025.2F10, MD.025.2B07, MD.025.2G11, MD.025.1F09, MD.025.1D01, MD.025.1H07, 306.012.7.1C10, 306.012.7.1A05, 10.036.7.1B04, 10.04.7.1B03

APT1 deficient mouse

Eastern Equine Encephalitis virus (EEEV) antibodies

Venezuelan equine encephalitis virus (VEEV) E2 DNA plasmid

Your Collections

Office of Technology Management